PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Novartis Institutes for BioMedical Research (NIBR) Translational Medicine, Cambridge, MA, United States.\', \'Novartis Institutes for BioMedical Research (NIBR), Translational Medicine, Basel, Switzerland.\', \'Department of Pediatrics I, University of Tübingen, Tübingen, Germany.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.3389/fimmu.2021.697405
?:hasPublicationType
?:journal
  • Frontiers in immunology
is ?:pmid of
?:pmid
?:pmid
  • 34220859
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.803
?:rankingScore_hIndex
  • 69
?:title
  • Myeloid-Derived Suppressor Cells as a Potential Biomarker and Therapeutic Target in COVID-19.
?:type

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34220859>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34220859>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all